about
sameAs
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerIdentification of Circulating Tumor DNA for the Early Detection of Small-cell Lung CancerIdentification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrationsMolecular Pathways: Targeting NRG1 Fusions in Lung Cancer.Genomic architecture of lung cancers.CD74-NRG1 fusions in lung adenocarcinoma.BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors.Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.New insights into the molecular characteristics of pulmonary carcinoids and large-cell neuroendocrine carcinomas, and the impact on their clinical management.Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposalRedefining mesothelioma types as a continuum uncovers the immune and vascular systems as key players in the diagnosis and prognosis of this diseaseEURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary ApproachHighlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypesIntegrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoidsNeedlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
P50
Q28303281-8C80A3BC-2FB0-43B6-966C-68B7DDAF2780Q28390093-E16666CA-704B-4952-AD7A-D28315EE011AQ30887494-CE30CB66-4B8F-47C4-B7A3-1E204F67379AQ34045543-9732A433-DEA1-4A3D-9ED1-2D111033CC37Q36140332-68FF8F8B-ADD1-455F-924C-57C430BDF6C9Q36905633-627E7964-2CF5-47B6-98D5-990A70A68AF2Q38287017-4FBCACA8-74DB-44C1-8C40-37E41F2AD70FQ38633851-E69ABDE1-28DA-4321-ACAD-B0107B8921DAQ39029951-5D368421-BA6F-4811-BEBF-5380D23CC735Q39051937-09565048-8F37-4948-A1D7-2C53EFAB98B9Q39692880-0DC5BD7E-3294-4EC1-AC6E-F2501F559DA3Q39716418-D7EB300C-7986-4100-A4A6-120AC3DE2C3FQ40491492-01F9BD7B-3F67-48FE-B980-E3C9E8C24EE7Q47608438-0CE60F69-E57B-4B2C-81F1-10422D5D3AFDQ49904416-B97C2EC2-8705-4CF7-865F-0DA7B4CD2E9BQ51763437-840DA4FD-9A19-4CA3-946C-FF52DD33C3F6Q56341375-C3659AE4-DD5C-4204-9C72-39E61AA8CB6EQ57788811-DC324235-97DD-4B11-84D7-9AEDDEBE2D20Q90220377-0BF38805-4F62-4FCD-9578-2A87810670F5Q91880355-83030F0F-CE78-46BB-A259-CA2B531149F1Q92735048-99F20722-C231-4B60-86FF-A388DA9126ECQ94503870-10CF9386-D317-4703-B249-8F6157CAB36B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lynnette Fernandez-Cuesta
@ast
Lynnette Fernandez-Cuesta
@en
Lynnette Fernandez-Cuesta
@es
Lynnette Fernandez-Cuesta
@nl
Lynnette Fernandez-Cuesta
@sl
type
label
Lynnette Fernandez-Cuesta
@ast
Lynnette Fernandez-Cuesta
@en
Lynnette Fernandez-Cuesta
@es
Lynnette Fernandez-Cuesta
@nl
Lynnette Fernandez-Cuesta
@sl
prefLabel
Lynnette Fernandez-Cuesta
@ast
Lynnette Fernandez-Cuesta
@en
Lynnette Fernandez-Cuesta
@es
Lynnette Fernandez-Cuesta
@nl
Lynnette Fernandez-Cuesta
@sl
P106
P21
P31
P496
0000-0002-0724-6703